Speaker illustration

Professor Edoardo Camenzind

University Hospital of Nancy , Nancy (France)

Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT randomized trial

Date: 8 August 2014

Journal: European Heart Journal

Thumbnail

Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type

Date: 13 March 2014

Journal: European Heart Journal

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb